Cabergoline Tablet
Product Images NDC 50090-6596

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cabergoline (NDC 50090-6596). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (D3e8a769 Cb6d 469c 9bf7 3fe577028668 01)

Structure (D3e8a769 Cb6d 469c 9bf7 3fe577028668 01)
Chemical structure diagram of cabergoline, showing the molecular arrangement of atoms and bonds characteristic of this active ingredient.*
FDA Label Image

Logo (D3e8a769 Cb6d 469c 9bf7 3fe577028668 02)

FDA Label Image

Label Image (Lbl500906596)

Label Image (Lbl500906596)
The label displays information for Cabergoline 0.5 mg oral tablets, a human prescription drug by A-S Medication Solutions. It includes the NDC 50090-6596-0, lot number 6753-0, storage instructions to keep between 68 to 77 degrees Fahrenheit, and a note that the package contains 8 tablets. The label also mentions that each tablet contains 0.5 mg of cabergoline.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.